| # | Drug | Count |
|---|---|---|
| 0 | CANAGLIFLOZIN | 117 |
| 1 | CYCLOPHOSPHAMIDE | 29 |
| 2 | CYCLOPHOSPHAMIDE FOR INJECTION | 29 |
| 3 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 29 |
| 4 | PREDNISOLONE | 26 |
| 5 | PREDNISOLONE ORAL | 26 |
| 6 | PREDNISOLONE ORAL SOLUTION | 26 |
| 7 | DEXAMETHASONE | 14 |
| 8 | DEXAMETHASONE 1.5 MG | 14 |
| 9 | DICLOFENAC SODIUM | 14 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CANAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | 13 | 0.0072 |
| 1 | CANAGLIFLOZIN | 117 | 0.0039 |
| 2 | ESMOLOL HYDROCHLORIDE | 1 | 0.0037 |
| 3 | 1169 HYDROGEN PEROXIDE SPRAY | 1 | 0.0032 |
| 4 | HYDROGEN PEROXIDE | 1 | 0.0030 |
| 5 | CASPOFUNGIN ACETATE | 4 | 0.0025 |
| 6 | CLINDAMYCIN PHOSPHATE | 10 | 0.0018 |
| 7 | DACTINOMYCIN | 3 | 0.0014 |
| 8 | VANCOMYCIN HYDROCHLORIDE | 11 | 0.0013 |
| 9 | ROPIVACAINE HYDROCHLORIDE | 3 | 0.0012 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 52 |
| 1 | Alkylating Drug [EPC] | 30 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 23 |
| 3 | Nucleoside Metabolic Inhibitor [EPC] | 19 |
| 4 | Microtubule Inhibitor [EPC] | 18 |
| 5 | Platinum-based Drug [EPC] | 17 |
| 6 | Catecholamine [EPC] | 13 |
| 7 | CD20-directed Cytolytic Antibody [EPC] | 12 |
| 8 | Glycopeptide Antibacterial [EPC] | 11 |
| 9 | Insulin Analog [EPC] | 11 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Actinomycin [EPC] | 3 | 0.0014 |
| 1 | Tetracycline-class Antibacterial [EPC] | 2 | 0.0003 |
| 2 | Antihypoglycemic Agent [EPC] | 1 | 0.0002 |
| 3 | alpha-1 Adrenergic Agonist [EPC] | 1 | 0.0002 |
| 4 | Penem Antibacterial [EPC] | 7 | 0.0002 |
| 5 | Sulfone [EPC] | 2 | 0.0002 |
| 6 | Glycopeptide Antibacterial [EPC] | 11 | 0.0002 |
| 7 | Phosphodiesterase 3 Inhibitor [EPC] | 1 | 0.0002 |
| 8 | Catecholamine [EPC] | 13 | 0.0002 |
| 9 | Dipeptidyl Peptidase 4 Inhibitor [EPC] | 5 | 0.0002 |